找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Clinical Management of Renal Tumors; Ronald M. Bukowski,Andrew C. Novick Book 2008 The Editor(s) (if applicable) and The Author(s), under

[复制链接]
楼主: POL
发表于 2025-3-23 13:47:41 | 显示全部楼层
Radical Nephrectomy,, and a lymph node dissection, removing the paraaortic and paracaval nodal packets from the crus of the diaphragm superiorly to the aortic bifurcation inferiorly. Since that time, the technique of radical nephrectomy has undergone some modification, but the general principles outlined remain germane to today’s contemporary practice.
发表于 2025-3-23 14:12:47 | 显示全部楼层
发表于 2025-3-23 20:13:44 | 显示全部楼层
发表于 2025-3-24 01:59:18 | 显示全部楼层
th renal cancer having localized or advanced disease are discussed. Surgical approaches for primary and metastatic tumors, symptom palliation, and systemic therapy for metastatic disease including immunotherapy and targeted approaches are discussed in detail..978-1-60761-469-2978-1-60327-149-3
发表于 2025-3-24 05:41:00 | 显示全部楼层
https://doi.org/10.1007/978-3-642-88120-6s and experimental studies. Furthermore, pathologists could allocate any redundant tumor tissues not required for diagnosis to basic research programs. Pathologists, urologists, and other clinicians play equally important roles in the optimal handling and processing of renal cell carcinoma specimens.
发表于 2025-3-24 09:32:14 | 显示全部楼层
发表于 2025-3-24 14:14:06 | 显示全部楼层
Probleme der Schädeldachplastikradiologic data will be of importance to validate results if a surrogate endpoint such as disease free survival is utilized. In view of our current knowledge of the biology of clear cell carcinoma, studies utiling medications such as sunitinib, sorafenib, or bevacizumab are considerations.
发表于 2025-3-24 18:17:02 | 显示全部楼层
发表于 2025-3-24 20:11:09 | 显示全部楼层
发表于 2025-3-25 01:57:43 | 显示全部楼层
Adjuvant Therapy of Renal Cell Carcinoma,radiologic data will be of importance to validate results if a surrogate endpoint such as disease free survival is utilized. In view of our current knowledge of the biology of clear cell carcinoma, studies utiling medications such as sunitinib, sorafenib, or bevacizumab are considerations.
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-7-6 02:40
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表